Market News
BioCryst Pharmaceuticals (BCRX) Q4 2019 Earnings Snapshot
— BioCryst Pharmaceuticals (NASDAQ: BCRX) reported a loss of $0.02 per share for the fourth quarter of 2019 vs. expected loss of $0.26 per share.…